Coagulation disorders may be a plausible hypothesis to explain how SARS-CoV-2 infection can induce brain hemorrhage, as patients with COVID-19 may suffer from consumption coagulopathy with prolonged prothrombin time and reduced fibrinogen, both of which also contribute to secondary cerebral hemorrhage.75 This evidence concerns the gene F2 and intracranial hemorrhage.